SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Global X Funds - Global X Defense Tech ETF

Global X Defense Tech ETF

The Global X Defense Tech ETF is trending as investors capitalize on surging worldwide military spending and a shift toward tech-driven, autonomous warfare. The community is actively discussing its potential for long-term growth driven by geopolitical tensions, with many highlighting its strategic exposure to both domestic defense contractors and international aerospace leaders.

VanEck ETF Trust - VanEck Junior Gold Miners ETF

VanEck Junior Gold Miners ETF

Junior gold miners are capturing significant attention as the ETF demonstrates a robust nested impulse rally, signaling strong bullish momentum that has the community actively debating the durability of the sector's breakout. Investors are closely monitoring the interplay between record gold prices and the sector's valuation, with many bullish traders viewing any short-term volatility as a strategic accumulation opportunity.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is experiencing heightened investor interest driven by anticipation for upcoming clinical data presentations and a potential BLA submission later this year. The community is actively discussing the stock's high short interest and limited effective float, fueling speculation about a possible short squeeze and long-term valuation potential relative to sector peers.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is facing extreme selling pressure and intense community scrutiny as investors grapple with multiple compression, executive departures, and a lack of positive guidance. While some see a generational buying opportunity near multi-year lows, others remain deeply frustrated by the stock's persistent underperformance and the CEO's lack of communication regarding rumored AI-driven catalysts.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is trending due to the launch of its ONBERG joint venture in Germany, which focuses on autonomous drone defense systems and has already secured live demonstrations. While the company is expanding its operational footprint across Europe, the stock continues to be a battleground between investors bullish on its defense technology integration and skeptics focused on dilution and ongoing legal challenges.

Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Capital Access Platforms, Financial Technology, and Market Services. The Capital Access Platforms segment delivers liquidity, transparency, and integrity to the corporate issuer and investment community by empowering clients to effectively navigate the capital markets, achieve their sustainability goals, and drive governance excellence. The Financial Technology segment offers platforms that improve the liquidity, transparency, and integrity of the global economy by architecting and operating the markets. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income, currency, and commodities trading. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

Nasdaq Inc - Ordinary Shares - 144A

Nasdaq Inc

Nasdaq is trending as the exchange pushes for SEC approval to expand to 23-hour trading, aiming to modernize market access while investors digest mixed economic data and ongoing geopolitical uncertainties. Community discussion remains heavily focused on potential market volatility, with active debates concerning the long-term impact of AI infrastructure spending and the overall resilience of the current tech-driven rally.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is currently trending as investors weigh its role as a high-beta proxy for Bitcoin against broader concerns over the Clarity Act, which remains a key focus for market participants anticipating potential regulatory shifts. The community is actively discussing Coinbase's technical setup and its correlation with BTC, with many traders debating whether the stock is setting up for a rebound or facing further downside risk.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending as investors digest news regarding its potential role in U.S. payment infrastructure alongside ongoing discussions surrounding regulatory clarity. Community sentiment remains deeply polarized, with bulls positioning for a long-term liquidity-driven breakout while bears voice skepticism over recent price action and institutional adoption timelines.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant momentum and renewed investor interest as positive early-stage clinical data for its siRNA muscle disorder pipeline validates the company's proprietary platform. While the stock continues to navigate regulatory skepticism and aggressive short interest, the community is focused on the potential for pipeline expansion to act as a catalyst for a long-term valuation shift.

APA Corp. explores for oil and natural gas through its subsidiaries. It produces oil and gas with operations in the United States, Egypt and the United Kingdom, and exploration activities offshore in Suriname. The company was founded in 1954 and is headquartered in Houston, TX.

APA Corporation

APA Corporation is trending as investors weigh mixed Q4 financial results, ongoing geopolitical instability affecting energy supply chains, and debate surrounding the company's capital efficiency in the current commodity cycle. Community sentiment is deeply divided, with some traders targeting the stock for dividend capture strategies while others express frustration over long-term price suppression and volatility relative to crude oil benchmarks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cardiol Therapeutics (TSE:CRDL) Trading Up 7.9% - Here's What Happened

Cardiol Therapeutics (TSE:CRDL) Stock Price Up 7.9% - Should You Buy...

Cardiol Therapeutics CEO: Phase III MAVERIC Nears Full Enrollment as CardiolRx Shows Myocarditis Promise

Cardiol Therapeutics (NASDAQ:CRDL) is aiming to address inflammation-driven heart disease with therapies the company believes could improve outcomes in conditions that currently have limited or no...

Research Analysts Set Expectations for CRDL Q3 Earnings

Cardiol Therapeutics Inc. (NASDAQ:CRDL - Free Report) - Equities researchers at Brookline Capital Markets reduced their Q3 2026 EPS estimates for shares of Cardiol Therapeutics in a research report...

What is HC Wainwright's Forecast for CRDL Q1 Earnings?

Cardiol Therapeutics Inc. (NASDAQ:CRDL - Free Report) - Equities researchers at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for shares of Cardiol Therapeutics in a research...

Cardiol Therapeutics (NASDAQ:CRDL) Earns "Buy" Rating from Canaccord Genuity Group

Canaccord Genuity Group reaffirmed a "buy" rating and issued a $8.00 price target on shares of Cardiol Therapeutics in a report on Monday...

Cardiol Therapeutics (NASDAQ:CRDL) Raised to Hold at Wall Street Zen

Wall Street Zen raised shares of Cardiol Therapeutics from a "sell" rating to a "hold" rating in a report on Sunday...

What is HC Wainwright's Estimate for CRDL FY2028 Earnings?

Cardiol Therapeutics Inc. (NASDAQ:CRDL - Free Report) - Research analysts at HC Wainwright boosted their FY2028 earnings per share estimates for Cardiol Therapeutics in a report issued on Thursday...

Cardiol Therapeutics (NASDAQ:CRDL) Posts Earnings Results, Beats Expectations By $0.04 EPS

Cardiol Therapeutics (NASDAQ:CRDL - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.09) by...

Cardiol Therapeutics (TSE:CRDL) Trading Up 10.5% - Time to Buy?

Cardiol Therapeutics (TSE:CRDL) Trading Up 10.5% - Still a Buy...

Cardiol Therapeutics (CRDL) Expected to Announce Quarterly Earnings on Wednesday

Cardiol Therapeutics (NASDAQ:CRDL) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-1-cardiol-therapeutics-inc-stock-1...

Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. The firm is conducting clinical studies to evaluate the efficacy and safety of CardiolRx in diseases affecting the heart: a Phase II multi-national, randomized, double-blind, placebo-controlled trial (the ARCHER trial) in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis. It is also involved in developing a novel subcutaneously administered drug formulation of cannabidiol intended for use in heart failure. The company was founded by David Elsley, Eldon Smith, and Anthony Bolton on January 19, 2017 and is headquartered in Oakville, Canada.

CRDL
Cardiol Therapeutics Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRDL News

CRDLCardiol Therapeutics Inc - Ordinary Shares - Class A